CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Feb. 7, 2024—Corista announced it has received a class II medical device license from Health Canada for its DP3 platform, a web-based image-management system for digital pathology.
“We’ve been building a world-class solution for integrated pathology,” Corista CEO and cofounder Elizabeth Wingard said in a press release. “Attaining the class II medical device license from Canada is an important milestone in making this possible.”
Pages: 1 2